ATE366733T1 - Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung - Google Patents

Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung

Info

Publication number
ATE366733T1
ATE366733T1 AT04732592T AT04732592T ATE366733T1 AT E366733 T1 ATE366733 T1 AT E366733T1 AT 04732592 T AT04732592 T AT 04732592T AT 04732592 T AT04732592 T AT 04732592T AT E366733 T1 ATE366733 T1 AT E366733T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
pioglitazone
pioglitazone sulfate
sulfate
useful
Prior art date
Application number
AT04732592T
Other languages
English (en)
Inventor
Jie Zhu
Frantisek Picha
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of ATE366733T1 publication Critical patent/ATE366733T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04732592T 2003-05-13 2004-05-13 Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung ATE366733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46983803P 2003-05-13 2003-05-13

Publications (1)

Publication Number Publication Date
ATE366733T1 true ATE366733T1 (de) 2007-08-15

Family

ID=33452331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04732592T ATE366733T1 (de) 2003-05-13 2004-05-13 Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung

Country Status (12)

Country Link
US (2) US7230016B2 (de)
EP (1) EP1622899B1 (de)
JP (1) JP2006528948A (de)
AT (1) ATE366733T1 (de)
AU (1) AU2004238537A1 (de)
CA (1) CA2525316A1 (de)
DE (1) DE602004007505T2 (de)
ES (1) ES2290709T3 (de)
IL (1) IL171875A0 (de)
NO (1) NO20055830L (de)
WO (1) WO2004101561A1 (de)
ZA (1) ZA200509155B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2005080387A2 (en) * 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
JP2008195625A (ja) * 2007-02-08 2008-08-28 Pharma Frontier Kk Ｇ蛋白質共役型レセプター抑制剤および医薬
KR101537830B1 (ko) 2007-09-14 2015-07-17 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 고혈압 치료용 티아졸리딘디온 유사체
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
WO2009071219A2 (en) * 2007-12-08 2009-06-11 Bayer Schering Pharma Aktiengesellschaft Oral dispersable tablet
JP5383123B2 (ja) * 2008-09-02 2014-01-08 株式会社トクヤマ ピオグリタゾン塩酸塩の製造方法
US20100060985A1 (en) 2008-09-09 2010-03-11 Fujifilm Corporation Method for producing polarizing plate, and automobile's windshield
TR201202048T2 (tr) * 2009-05-26 2012-04-24 Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇@ Pioglitazon çözeltisi ile kaplanmış metformin.
KR20120107493A (ko) 2009-12-15 2012-10-02 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염
US20120322728A1 (en) * 2009-12-15 2012-12-20 Metabolic Solutions Development Company, Llc Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone
RU2636483C2 (ru) * 2012-09-21 2017-11-23 Реоксин Дискавериз Груп, Инк. Ячейка для электролиза жидкости

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
FI91869C (fi) 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
EP0506273B1 (de) 1991-03-25 1995-05-31 Takeda Chemical Industries, Ltd. Verfahren zur Herstellung von Ethern
JPH07138258A (ja) 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
CA2195559A1 (en) 1994-08-10 1996-02-22 Takashi Sohda Thiazolidinedione derivatives, their production and use
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5814647A (en) 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
SE9702305D0 (sv) 1997-06-17 1997-06-17 Astra Ab New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
US7009057B2 (en) 2001-04-26 2006-03-07 Zentiva A.S. Method for obtaining pioglitazone as an antidiabetic agent
WO2004101560A1 (en) 2003-05-13 2004-11-25 Synthon B.V. Processes for making thiazolidinedione derivatives and compounds thereof
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same

Also Published As

Publication number Publication date
US20070203199A1 (en) 2007-08-30
WO2004101561A1 (en) 2004-11-25
NO20055830D0 (no) 2005-12-08
US20050054684A1 (en) 2005-03-10
EP1622899B1 (de) 2007-07-11
US7230016B2 (en) 2007-06-12
DE602004007505T2 (de) 2008-03-13
AU2004238537A1 (en) 2004-11-25
NO20055830L (no) 2005-12-08
CA2525316A1 (en) 2004-11-25
ZA200509155B (en) 2007-04-25
DE602004007505D1 (de) 2007-08-23
EP1622899A1 (de) 2006-02-08
ES2290709T3 (es) 2008-02-16
IL171875A0 (en) 2006-04-10
JP2006528948A (ja) 2006-12-28

Similar Documents

Publication Publication Date Title
CY2015009I1 (el) Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
CY1120377T1 (el) Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη
ATE366733T1 (de) Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ITPD20020138A0 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
DE602004015134D1 (de) Saugfähige artikel mit metallbeladenen nanoteilchen
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
CY1116554T1 (el) Αλατα κλοπιδογρελης και μεθοδος παρασκευης
MX2009005696A (es) Nanoparticulas magneticas para la aplicacion en hipertermia, preparacion de las mismas y uso en constructos que tienen una aplicacion farmacologica.
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
DE602004020907D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
DE60307632D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
BR0208566B1 (pt) Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica
ITFI20020038A1 (it) Coloranti ceramici in forma di sospensioni nanometriche
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
ATE405559T1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
DE602004016015D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
DE602004017514D1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
ATE332140T1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
TW200733954A (en) Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties